Sustained nitric oxide synthesis contributes to immunopathology in ongoing myocarditis attributable to interleukin-10 disorders.
暂无分享,去创建一个
A. Weinzierl | K. Klingel | M. Sauter | R. Kandolf | G. Szalay | J. Hald
[1] P. Tripathi. Nitric oxide and immune response. , 2007, Indian journal of biochemistry & biophysics.
[2] R. Zell,et al. Interferon-gamma-induced activation of nitric oxide-mediated antiviral activity of macrophages caused by a recombinant coxsackievirus B3. , 2005, Viral immunology.
[3] N. Rose,et al. IL-12 Protects against Coxsackievirus B3-Induced Myocarditis by Increasing IFN-γ and Macrophage and Neutrophil Populations in the Heart1 , 2005, The Journal of Immunology.
[4] S. Palaniyandi,et al. Inhibition of mast cells by interleukin‐10 gene transfer contributes to protection against acute myocarditis in rats , 2004, European journal of immunology.
[5] T. Yajima,et al. Interleukin-10: biomarker or pathologic cytokine in fulminant myocarditis? , 2004, Journal of the American College of Cardiology.
[6] I. Takeuchi,et al. Serum levels of interleukin-10 on admission as a prognostic predictor of human fulminant myocarditis. , 2004, Journal of the American College of Cardiology.
[7] K. Klingel,et al. Molecular pathology of inflammatory cardiomyopathy , 2004, Medical Microbiology and Immunology.
[8] K. Klingel,et al. beta2-microglobulin-associated regulation of interferon-gamma and virus-specific immunoglobulin G confer resistance against the development of chronic coxsackievirus myocarditis. , 2003, The American journal of pathology.
[9] I. Kerr,et al. The Antiviral Response to Gamma Interferon , 2002, Journal of Virology.
[10] F. Leuschner,et al. Cutting Edge: A Critical Role for IL-10 in Induction of Nasal Tolerance in Experimental Autoimmune Myocarditis1 , 2002, The Journal of Immunology.
[11] J. Miyazaki,et al. Protection Against Autoimmune Myocarditis by Gene Transfer of Interleukin-10 by Electroporation , 2001, Circulation.
[12] R. Zell,et al. Expression of Immunoregulatory Cytokines by Recombinant Coxsackievirus B3 Variants Confers Protection against Virus-Caused Myocarditis , 2001, Journal of Virology.
[13] D. Gemsa,et al. Persistent expression of cytokines in the chronic stage of CVB3-induced myocarditis in NMRI mice. , 2001, Journal of molecular and cellular cardiology.
[14] D. Gemsa,et al. Suppression of proinflammatory cytokines and induction of IL‐10 in human monocytes after coxsackievirus B3 infection , 2001, Journal of medical virology.
[15] S Sasayama,et al. Cytokine gene therapy for myocarditis by in vivo electroporation. , 2001, Human gene therapy.
[16] S. Marsch,et al. Lethal Autoimmune Myocarditis in Interferon-&ggr; Receptor–Deficient Mice: Enhanced Disease Severity by Impaired Inducible Nitric Oxide Synthase Induction , 2001, Circulation.
[17] R. Rhoads,et al. Nitric Oxide Inhibits Dystrophin Proteolysis by Coxsackieviral Protease 2A Through S-Nitrosylation: A Protective Mechanism Against Enteroviral Cardiomyopathy , 2000, Circulation.
[18] N. Sarvetnick,et al. Pancreatic expression of interferon-γ protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis , 2000, Nature Medicine.
[19] F. Rodríguez,et al. The role of B lymphocytes in coxsackievirus B3 infection. , 1999, The American journal of pathology.
[20] T. Mak,et al. Susceptibility to Myocarditis Is Dependent on the Response of αβ T Lymphocytes to Coxsackieviral Infection , 1999 .
[21] A. Matsumori,et al. Treatment of experimental viral myocarditis with interleukin-10. , 1999, Circulation.
[22] Zhang,et al. Induction of myocardial nitric oxide synthase by Coxsackie B3 virus in mice , 1999, European journal of clinical investigation.
[23] F. Marumo,et al. Nitric oxide induces apoptotic death of cardiomyocytes via a cyclic-GMP-dependent pathway. , 1999, Experimental cell research.
[24] C. Lowenstein,et al. The role of inducible nitric oxide synthase in the host response to Coxsackievirus myocarditis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[25] C. Lowenstein,et al. Nitric oxide inhibition of coxsackievirus replication in vitro. , 1997, The Journal of clinical investigation.
[26] Y. Yazaki,et al. Expression of cytokine mRNAs in murine hearts with acute myocarditis caused by coxsackievirus B3 , 1997, The Journal of pathology.
[27] P. Efron,et al. Nitric oxide, an autocrine regulator of wound fibroblast synthetic function. , 1997, Journal of immunology.
[28] J S Beckman,et al. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. , 1996, The American journal of physiology.
[29] J. Whitton,et al. The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis , 1995, Journal of virology.
[30] M. Radomski,et al. Myocardial calcium-independent nitric oxide synthase activity is present in dilated cardiomyopathy, myocarditis, and postpartum cardiomyopathy but not in ischaemic or valvar heart disease. , 1995, British heart journal.
[31] T. Martino,et al. Viral infection and the pathogenesis of dilated cardiomyopathy. , 1994, Circulation research.
[32] P. Hofschneider,et al. Molecular cloning of the genome of a cardiotropic Coxsackie B3 virus: full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[33] N. Rose,et al. Interferon- Protects against Chronic Viral Myocarditis by Reducing Mast Cell Degranulation, Fibrosis, and the Profibrotic Cytokines Transforming Growth Factor- 1, Interleukin-1 , and Interleukin-4 in the Heart , 2004 .
[34] N. Rose,et al. Interferon-gamma protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-beta 1, interleukin-1 beta, and interleukin-4 in the heart. , 2004, The American journal of pathology.
[35] K. Klingel,et al. Pathogenesis of Coxsackievirus В Infections , 2002 .
[36] B. Semler,et al. Molecular biology of picornaviruses , 2002 .
[37] R. Coffman,et al. Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.
[38] T. Mak,et al. Susceptibility to myocarditis is dependent on the response of alphabeta T lymphocytes to coxsackieviral infection. , 1999, Circulation research.
[39] K. Klingel,et al. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[40] B. McManus,et al. Enteroviral infection of mice with severe combined immunodeficiency. Evidence for direct viral pathogenesis of myocardial injury. , 1992, Laboratory investigation; a journal of technical methods and pathology.
[41] M. Capobianchi,et al. Role of interferon in lethality and lymphoid atrophy induced by Coxsackievirus B3 infection in mice. , 1991, Viral immunology.
[42] H. Arizpe,et al. Characterization of the antibody response in vaccinated mice protected against Coxsackievirus B3-induced myocarditis. , 1987, Viral immunology.